Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy. 1987

J Belleney, and B P Roques, and M C Fournie-Zaluski
Department of Organic Chemistry, INSERM, CNRS, UER of Pharmaceutical and Biological Sciences, Paris, France.

The preferential conformations of the delta selective opioid peptides DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) and DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) were studied by 400 MHz 1H n.m.r. spectroscopy in DMSO-d6 solution. In neutral conditions, the weak NH temperature coefficients of the C-terminal residue (Pen5 or Thr6), associated with interproton NH-NH and alpha-NH NOE's (ROESY experiments), indicated large analogies between the backbone folding tendency of both the linear and cyclic peptides. Various gamma and/or beta turns may account for these experimental data. A similar orientation of the N-terminal tyrosine related to the folded backbones is observed for the two agonists, with a probable gamma turn around the amino acid in position 2. Finally, a short distance, about 10 A, between Tyr and Phe side chains and identical structural roles for threonyl and penicillamino residues are proposed for both peptides. These results suggest the occurrence of similar conformers in solution for the constrained peptide DPLPE and the flexible hexapeptide DTLET. Therefore, it may be hypothesized that the enhanced delta selectivity of DPLPE is related to a very large conformational expense of energy needed to interact with the mu opioid receptor, a feature not encountered in the case of DTLET. These findings might allow peptides to be designed retaining a high affinity for delta opioid receptors associated with a very low cross-reactivity with mu binding sites.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D020881 Enkephalin, D-Penicillamine (2,5)- A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity. D-Pen2, D-Pen5-Enkephalin,D-Penicillamine (2,5)-Enkephalin,DPDPE,Bis-Pen-Enkephalin,Bis-Penicillamine-Enkephalin,D-Pen2, L-Pen5-Enkephalin,DPDPE(SH)2,DPLPE,Enkephalin, Pen(2,5)-,Enkephalin, Penicillamine (2,5)-,Bis Pen Enkephalin,Bis Penicillamine Enkephalin,D Pen2, D Pen5 Enkephalin,D Pen2, L Pen5 Enkephalin,D-Pen5-Enkephalin D-Pen2,L-Pen5-Enkephalin D-Pen2

Related Publications

J Belleney, and B P Roques, and M C Fournie-Zaluski
May 1992, European journal of pharmacology,
J Belleney, and B P Roques, and M C Fournie-Zaluski
December 1977, Biochemical and biophysical research communications,
J Belleney, and B P Roques, and M C Fournie-Zaluski
February 1988, International journal of peptide and protein research,
J Belleney, and B P Roques, and M C Fournie-Zaluski
September 1980, FEBS letters,
J Belleney, and B P Roques, and M C Fournie-Zaluski
March 1983, Biochemical and biophysical research communications,
J Belleney, and B P Roques, and M C Fournie-Zaluski
January 1986, NIDA research monograph,
J Belleney, and B P Roques, and M C Fournie-Zaluski
January 1995, Archives internationales de pharmacodynamie et de therapie,
J Belleney, and B P Roques, and M C Fournie-Zaluski
November 1982, International journal of peptide and protein research,
Copied contents to your clipboard!